Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

539
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
539
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.7K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.7K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

599
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
599
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

390
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
390
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

479
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
479
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

627
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
627

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carotid Bypass: Insights from a Real World Multicentre French Cohort.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026
Same author

Evaluating Four HIT Prediction Scores After Cardiac Surgery With Cardiopulmonary Bypass: A Comparative Study.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Clinical characteristics and treatments of imported loiasis patients with microfilaraemia diagnosed in France, 2000-2022.

Travel medicine and infectious disease·2026
Same author

Machine-learning approach on echocardiography to improve the detection of transthyretin amyloid cardiomyopathy: GRAAL algorithm.

European heart journal. Digital health·2026
Same author

Cardiac MRI differentiates classical idiopathic pulmonary arterial hypertension from lung phenotype and group 3 pulmonary hypertension.

Respiratory medicine and research·2026
Same author

Pathogenesis of gaseous microemboli in cardiac surgery. a comprehensive overview of deairing procedures, operative interactions and risk factors to mitigate postoperative cerebral disorders.

Journal of cardiothoracic surgery·2026

Related Experiment Video

Updated: May 6, 2026

Arterial Pouch Microsurgical Bifurcation Aneurysm Model in the Rabbit
06:11

Arterial Pouch Microsurgical Bifurcation Aneurysm Model in the Rabbit

Published on: May 14, 2020

2.3K

Management of Infectious Aortic Aneurysms: Short- and Mid-TermOutcomes.

Simon Frisch1, Nicla Settembre2, Rabie Ali Belkorissat1

  • 1Department of Vascular and Endovascular Surgery, Nancy University Hospital, University of Lorraine, Nancy, France.

Annals of Vascular Surgery
|March 7, 2025
PubMed
Summary

Radical open surgery combined with antibiotics is effective for infectious aortic aneurysms (IAA). Endovascular treatment offers acceptable results, while medical management is reserved for inoperable patients with high mortality risk.

More Related Videos

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm
05:07

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm

Published on: August 2, 2024

694
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

174

Related Experiment Videos

Last Updated: May 6, 2026

Arterial Pouch Microsurgical Bifurcation Aneurysm Model in the Rabbit
06:11

Arterial Pouch Microsurgical Bifurcation Aneurysm Model in the Rabbit

Published on: May 14, 2020

2.3K
Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm
05:07

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm

Published on: August 2, 2024

694
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

174

Area of Science:

  • Cardiovascular Surgery
  • Infectious Diseases
  • Vascular Surgery

Background:

  • Infectious aortic aneurysms (IAA) are rare, rapidly developing, and life-threatening vascular conditions.
  • Management requires a multidisciplinary approach.
  • Evaluating treatment outcomes and mortality factors is crucial for IAA patients.

Purpose of the Study:

  • To assess the mortality rates of patients treated for infectious aortic aneurysm (IAA) using various therapeutic strategies.
  • To investigate infectious recurrence rates and identify factors influencing mortality in IAA management.

Main Methods:

  • A retrospective study included 47 patients with confirmed IAA between September 2009 and October 2023.
  • Treatments included radical open surgery with biological reconstruction, endovascular repair, or medical management.
  • Data collected included clinical, biological, microbiological, radiological, and nuclear medicine findings, with 30-day, 1-year, and 3-year follow-ups.

Main Results:

  • Overall 30-day, 1-year, and 3-year survival rates were 78.7%, 52.4%, and 44.4%, respectively.
  • Radical open surgery showed higher survival rates (60.6% at 3 years) compared to endovascular treatment (20.8% at 3 years).
  • Medical treatment alone resulted in 0% survival at 3 years for persistent infections.

Conclusions:

  • Combining medical treatment with radical open surgery is an effective strategy for managing infectious aortic aneurysms.
  • Endovascular treatment provides acceptable outcomes for IAA.
  • Medical management should be reserved for inoperable patients due to high mortality risks.